SHPG
SHPG Articles
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
Published:
AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira anti-inflammatory drug.
Published:
Last Updated:
The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. Here are some of the top stocks started with a rating of Buy at Jefferies.
Published:
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large...
Published:
ThinkstockStocks have had gains for eight weeks now and the stock market keeps challenging all-time highs. It is time for investors to start positioning their assets and portfolios for 2014. 24/7...
Published:
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical company...
Published:
Jon OggEarnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new Fed...
Published:
Jon OggAs a government shutdown and debt ceiling debate rage on as new (or repetitive) market risks, investors have to decide which stocks to buy and which to sell or avoid. 24/7 Wall St. reviews...
Published:
ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that target rare or hard to treat diseases as...
Published:
Last Updated:
Jon OggInvestors often get to see the analyst upgrades and Buy ratings from Wall Street firms. What investors frequently do not get to see is when those same analysts issue downgrades or when they...
Published:
Last Updated:
Jon OggInvestors frequently see analyst upgrades and Buy ratings from Wall Street research calls, but they often do not get to see the so-called Sell ratings. 24/7 Wall St. reviews many fresh...
Published:
Last Updated:
Jon Ogg24/7 Wall St. has tracked many stocks on the move in the last week. Now it is the weekend and this can be considered your weekend cheat sheet for the stocks you need to have your eye on come...
Published:
Last Updated:
ThinkstockThe hunt by Big Pharma stocks for smaller drug companies and biotech stocks continues. A report citing “sources” from Dow Jones News has signaled that Bristol-Myers Squibb (NYSE: BMY)...
Published:
Last Updated: